{"id":200521,"name":"OVARIAN CANCER RESEARCH FUND ALLIANCE","slug":"ovarian-cancer-research-fund-alliance","state":"DC","country":"United States of America","description":"","totalSpending":0,"filings":32,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["OVARIAN CANCER RESEARCH FUND ALLIANCE"],"lobbyists":["CHAD RAMSEY","VANESSA CRAMER"],"govEntities":["Centers For Disease Control & Prevention (CDC)","HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["FY18 and FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.","FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.","FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.","FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.","Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations \nSupport for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bil"]}